UNVERIFIEDSingle Source
STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
Stat News|2/13/2026
P
Pharmaceuticals
106 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
53
Activity (Last 30 Days)
1
4
3
4
10
5
2
6
3
6
6
3
2026-01-262026-02-13
Top Publishers
Stat News53 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/13/2026
UNVERIFIEDSingle Source
Opinion: Pharmacist oversight must be built into prescription kiosks
Stat News|2/13/2026
UNVERIFIEDSingle Source
STAT+: Moderna’s president weighs in on FDA’s decision not to review its flu vaccine
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: BridgeBio drug for genetic cause of dwarfism succeeds in key study
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested
Stat News|2/11/2026
UNVERIFIEDSingle Source
Opinion: My granddaughter has a rare disease. But clinical trials often exclude patients like her
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Biotechs, wary of being tied to Big Pharma, form new industry group as hedge against Trump policies
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Novartis’ biomedical research head on AI, pruning the pipeline, and a potential blockbuster
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Trump administration revives effort to launch pilot initiative reworking drug discount program
Stat News|2/10/2026
UNVERIFIEDSingle Source
STAT+: OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuary
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: FDA warned a Hims & Hers compounder after finding bugs and failing to report a serious side effect
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: The risk score shuffle, and TrumpRx’s not-so-great deals
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Biotech doubles financing in quest to silence genes behind neurological diseases
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Hims & Hers will stop selling compounded version of Novo’s obesity pill
Stat News|2/7/2026
UNVERIFIEDSingle Source
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News|2/7/2026
UNVERIFIEDSingle Source
STAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease
Stat News|2/6/2026
UNVERIFIEDSingle Source
Statins don’t cause most of the side effects on package warnings, study finds
Stat News|2/5/2026
UNVERIFIEDSingle Source
Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: A rival goes after Ocular Therapeutix on eve of pivotal readout on eye treatment
Stat News|2/5/2026
UNVERIFIEDSingle Source
What to know about TrumpRx, the Trump administration’s prescription drug platform
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Nektar Therapeutics is trying to stage a comeback. But a big test awaits
Stat News|2/5/2026
UNVERIFIEDSingle Source
A sneak peek of pharma’s Super Bowl ads: GLP-1s, tight ends, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
The FDA wants to rein in drug ads. On Super Bowl Sunday, it will be business as usual
Stat News|2/5/2026
UNVERIFIEDSingle Source
New PBM law could open door to direct sales between employers, drugmakers
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News|2/4/2026
UNVERIFIEDSingle Source
Opinion: I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Pfizer moves forward with its hopes for a monthly obesity drug
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on imports
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Sanofi is reprimanded by a U.K. trade group for misleading claims about a Pfizer vaccine
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: As its immunology work draws attention, Sanofi also pushes forward in rare disease
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Hospital group wants Trump administration to block a new Lilly policy on 340B claims data
Stat News|1/26/2026